Scientists at Swansea University say they have made a breakthrough which could revolutionise prostate cancer treatment. Researchers at the university’s School of Medicine have developed a way of shrinking cancer cells using a harmless strain of salmonella bacteria. Read the article here.
Salmonella could shrink prostate cancer cells Read More »
Because PSA is secreted both by normal cells and cancer cells, its levels could be high for other reasons and not necessarily cancer: age, an inflammation of the prostate gland, or even a bicycle ride. But most often when doctors receive a high reading, they send their patients to do a biopsy, just to be on the safe side. Cleveland Diagnostics is developing a technology and test kit that can identify the PSA that specifically comes from cancer cells. Read the article here.
New prostate cancer test strives to slash biopsies Read More »
Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. After over 5 years of active surveillance, he describes his continuing quest to make the best — and most informed — decision about his care. Read the article here.
Prostate Cancer: New Directions With Active Surveillance Read More »
Dr. Juanita Crook, formerly with Princess Margaret Hospital, is now a professor of radiation oncology at UBC and an oncologist with the B.C. Cancer Agency. She specializes in brachytherapy. Read the article here.
Woman to Watch: Dr. Juanita Crook Read More »
The introduction of multiparametric MRI (mpMRI) has improved the diagnosis and risk stratification of intermediate and high-risk prostate cancer. In addition to diagnosis, mpMRI has increasingly become a useful tool for monitoring the prostate cancer risk of patients on active surveillance (AS) programmes. Long-term data indicates that there is no oncological benefit for AS programmes for patients diagnosed with intermediate risk prostate cancer. Further, there is increasing evidence that PI-RADS 4 lesion on mpMRI correlates with intermediate and high-risk prostate cancer. Read the article here.
Dr. George Suarez, a Miami urologist, is unabashed in his enthusiasm for high-intensity focused ultrasound (HIFU), the use of ultrasound waves energy to destroy cancerous prostate cells. But not all urologists share in his excitement, and many express skepticism whether the benefits outweigh the risks. Dr. Peter Scardino, a urologist and chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center, is one of them. “When I look at the results of HIFU for prostate cancer—which has been used in Europe for the last 15 years—what I see is cancer control rates that are no better than radiation
HIFU: Wave of the Future? Read More »
Hacking, the unauthorized access to data, is common these days. There are no federal requirements for cybersecurity standards on hospital equipment, which means once these machines are on a hospital’s network – and there are thousands in every hospital. Billy Rios, a cybersecurity expert, says most are easily hacked. Settings and critical information can be changed. Read the article here.
The headline reads: ‘His disease has disappeared’: Man ‘cured’ of advanced prostate cancer with shock doses of testosterone A possible new treatment option? Read the article.
New Treatment for Advanced PC? Read More »
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Nov. Awareness Night: Dr. Andrew Matthew: Sexual Health and Prostate Cancer Meet Our New Chairman, Philip Segal The important role of our Side by Side support group Coming Jan. Awareness Night: Dr. Raj Satkunasivam: The future of PSA-based prostate cancer screening: screening smarter and individualized risk assessment Rock the Road Raffle The 9th W.B. Ingalls Memorial Prostate Health & Cancer Symposium – Jan. 28th in Florida Meet the newest member of our board – Darryl Radstake A thank you to our volunteers Ask the Doctor:
Newsletter December 2016 Read More »
November 2014 Awareness Night – 20th Anniversary Celebration Watch this video of our 20th anniversary celebration: A bit of history from our founding as Man to Man to our joining the Prostate Cancer Canada Network Congratulatory messages from the medical community Our position on PSA testing as presented by PCC’s President and CEO Rocco Rossi CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 54:38 minutes
20th Anniversary Video Read More »